Negin Badrooj
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Negin Badrooj has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Sakineh Shab-Bidar
Department of Community Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences (TUMS), Tehran, Iran
3 shared publications Ahmad Jayedi
Semnan Univ Med Sci, Social Determinants Hlth Res Ctr, Semnan, Iran
1 shared publication- Ahmad Jayedi
Department of Epidemiology and Biostatistics, School of Public Health, Imperial College, London, UK
1 shared publication - Alireza Esteghamati
Endocrinology and Metabolism Research Center (EMRC) Vali‐Asr Hospital, Tehran University of Medical Sciences Tehran Iran
1 shared publication Alireza Soleimani
Department of Internal Medicine, Kashan University of Medical Sciences, Kashan, Iran
1 shared publication- Fereshteh Bahmani
Department of Clinical Biochemistry, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
1 shared publication
Latest Publications
- Open Access
- 11 April 2026
- Published by Wiley in Endocrinology, Diabetes & Metabolism
- Vol. 9 (3) , e70209
The Effect of Integrated Lifestyle Intervention Incorporating Calorie‐Carbohydrate Restriction With or Without Time‐Restricted Feeding for Remission of Type 2 Diabetes ( DIREM ): A Single Blind Randomised Controlled Trial
Aims: We conducted the diet and diabetes remission (DIREM) study to assess whether an integrated lifestyle intervention would lead to achieving remission in type 2 diabetes. Materials and Methods: Patients with type 2 diabetes were randomly assigned to calorie‐carbohydrate restriction (CCR) group, intermittent fasting with calorie‐carbohydrate restriction (IFCCR), or usual care group (control). The total study duration was 6 months, consisting of two phases: a 12‐week integrated lifestyle intervention (ILI) phase, followed by a 12‐week maintenance and structured monitoring (MSM) phase. The intervention was presented in the form of a structured behavioural model and also emphasised physical activity. Results: One hundred and twenty participants were randomly assigned to the study. Diabetes remission occurred in 9 (22.5%) of 40 participants in the CCR group (OR (CCR vs. Control) = 11.7, 95% CI: 1.4–98.3; p = 0.024), 12 (30.0%) of 40 participants in the IFCCR group (OR (IFCCR vs. Control) = 18.1, 95% CI: 2.2–151.0; p = 0.007) and 1 (2.5%) of 40 participants in the control group. The odds of remission were higher in the IFCCR group compared to the CCR group, but it was not significant (OR (IFCCR vs. CCR) = 1.5, 95% CI: 0.6–4.3; p = 0.4). Conclusions: Both calorie‐carbohydrate restriction alone and in combination with intermittent fasting significantly improved glycemic control and induced diabetes remission compared with the control group. No significant difference was found between the two interventions. Larger long‐term studies are needed to confirm these findings. Trial Registration: This trial was registered in the Iranian Registry of Clinical Trials (IRCT), IRCT20240418061519N1 ( https://trialsearch.who.int/Trial2.aspx?TrialID=IRCT20240418061519N1 )
- 11 April 2026
- Published by Wiley in Endocrinology, Diabetes & Metabolism
- Vol. 9 (3) , e70209
Open AccessThe Effect of Integrated Lifestyle Intervention Incorporating Calorie‐Carbohydrate Restriction With or Without Time‐Restricted Feeding for Remission of Type 2 Diabetes ( DIREM ): A Single Blind Randomised Controlled Trial
Aims: We conducted the diet and diabetes remission (DIREM) study to assess whether an integrated lifestyle intervention would lead to achieving remission in type 2 diabetes. Materials and Methods: Patients with type 2 diabetes were randomly assigned to calorie‐carbohydrate restriction (CCR) group, intermittent fasting with calorie‐carbohydrate restriction (IFCCR), or usual care group (control). The total study duration was 6 months, consisting of two phases: a 12‐week integrated lifestyle intervention (ILI) phase, followed by a 12‐week maintenance and structured monitoring (MSM) phase. The intervention was presented in the form of a structured behavioural model and also emphasised physical activity. Results: One hundred and twenty participants were randomly assigned to the study. Diabetes remission occurred in 9 (22.5%) of 40 participants in the CCR group (OR (CCR vs. Control) = 11.7, 95% CI: 1.4–98.3; p = 0.024), 12 (30.0%) of 40 participants in the IFCCR group (OR (IFCCR vs. Control) = 18.1, 95% CI: 2.2–151.0; p = 0.007) and 1 (2.5%) of 40 participants in the control group. The odds of remission were higher in the IFCCR group compared to the CCR group, but it was not significant (OR (IFCCR vs. CCR) = 1.5, 95% CI: 0.6–4.3; p = 0.4). Conclusions: Both calorie‐carbohydrate restriction alone and in combination with intermittent fasting significantly improved glycemic control and induced diabetes remission compared with the control group. No significant difference was found between the two interventions. Larger long‐term studies are needed to confirm these findings. Trial Registration: This trial was registered in the Iranian Registry of Clinical Trials (IRCT), IRCT20240418061519N1 ( https://trialsearch.who.int/Trial2.aspx?TrialID=IRCT20240418061519N1 )
- Open Access
- 8 April 2025
- Published by Springer Nature in Journal of Health, Population and Nutrition
- Vol. 44 (1) , 1-15
Comparative effects of different macronutrient compositions for type 2 diabetes management: a systematic review and network meta-analysis of randomized trials
To assess and rank the comparative effects of different exact macronutrient compositions for type 2 diabetes management rather than examining single macronutrients or as a dietary pattern. PubMed, Scopus, and Cochrane Library Central Register of Controlled Trials were searched. Randomized controlled trials were included. A random-effects network meta-analysis with a Bayesian framework was performed to calculate the mean difference (MD) and 95% credible intervals (CrIs). The certainty of evidence was rated using the GRADE approach. 80 trials with 9232 patients with type 2 diabetes were included in the network meta-analysis. A very low-carbohydrate, high-protein, and calorie-restricted diet had the greatest effect on reducing HbA1c (range of mean difference: − 1.0% to − 1.79%), weight (range of mean difference: -5.83 kg to -10.96 kg), and FPG (range of mean difference: − 2.20 mmol/L to − 2.88 mmol/L) at 6-month follow-up, but at 12-month follow-up, the effect remained only for HbA1c (range of mean difference: − 1.25% to − 1.30%) and FPG (range of mean difference: − 1.21 mmol/L to − 1.27 mmol/L). For weight loss in 12-month follow-up, the low-carbohydrate, high-protein diet was probably the most effective approach (range of mean difference: − 10.05 kg to − 14.52 kg). The best dietary approach to reduce LDL at 6-month follow-up was a low carbohydrate, high protein, calorie-restricted diet (range of mean difference: − 0.49 mmol/L to − 0.59 mmol/L) and at 12-month follow-up, a moderate carbohydrate, standard protein, calorie-restricted diet was effective in reducing LDL (mean difference: − 0.87 mmol/L, 95%CrI − 1.55 to − 0.16). A very low carbohydrate, high protein, calorie-restricted diet can be an effective dietary composition in managing diabetes, but milder dietary carbohydrate restriction for weight loss in the long-term, and improving lipid profiles is needed.
- 8 April 2025
- Published by Springer Nature in Journal of Health, Population and Nutrition
- Vol. 44 (1) , 1-15
Open AccessComparative effects of different macronutrient compositions for type 2 diabetes management: a systematic review and network meta-analysis of randomized trials
To assess and rank the comparative effects of different exact macronutrient compositions for type 2 diabetes management rather than examining single macronutrients or as a dietary pattern. PubMed, Scopus, and Cochrane Library Central Register of Controlled Trials were searched. Randomized controlled trials were included. A random-effects network meta-analysis with a Bayesian framework was performed to calculate the mean difference (MD) and 95% credible intervals (CrIs). The certainty of evidence was rated using the GRADE approach. 80 trials with 9232 patients with type 2 diabetes were included in the network meta-analysis. A very low-carbohydrate, high-protein, and calorie-restricted diet had the greatest effect on reducing HbA1c (range of mean difference: − 1.0% to − 1.79%), weight (range of mean difference: -5.83 kg to -10.96 kg), and FPG (range of mean difference: − 2.20 mmol/L to − 2.88 mmol/L) at 6-month follow-up, but at 12-month follow-up, the effect remained only for HbA1c (range of mean difference: − 1.25% to − 1.30%) and FPG (range of mean difference: − 1.21 mmol/L to − 1.27 mmol/L). For weight loss in 12-month follow-up, the low-carbohydrate, high-protein diet was probably the most effective approach (range of mean difference: − 10.05 kg to − 14.52 kg). The best dietary approach to reduce LDL at 6-month follow-up was a low carbohydrate, high protein, calorie-restricted diet (range of mean difference: − 0.49 mmol/L to − 0.59 mmol/L) and at 12-month follow-up, a moderate carbohydrate, standard protein, calorie-restricted diet was effective in reducing LDL (mean difference: − 0.87 mmol/L, 95%CrI − 1.55 to − 0.16). A very low carbohydrate, high protein, calorie-restricted diet can be an effective dietary composition in managing diabetes, but milder dietary carbohydrate restriction for weight loss in the long-term, and improving lipid profiles is needed.
- 6 July 2023
- Published by Elsevier in Nutrition, Metabolism and Cardiovascular Diseases
- Vol. 33 (11) , 2067-2075
Ideal cardiovascular health metrics and risk of type 2 diabetes: A systematic review and dose-response meta-analysis of prospective cohort studies
- 6 July 2023
- Published by Elsevier in Nutrition, Metabolism and Cardiovascular Diseases
- Vol. 33 (11) , 2067-2075
Ideal cardiovascular health metrics and risk of type 2 diabetes: A systematic review and dose-response meta-analysis of prospective cohort studies
- Retracted
- 1 February 2017
- Published by Elsevier in Clinical Nutrition
- Vol. 36 (1) , 79-84
RETRACTED: Metabolic response to omega-3 fatty acid supplementation in patients with diabetic nephropathy: A randomized, double-blind, placebo-controlled trial
- 1 February 2017
- Published by Elsevier in Clinical Nutrition
- Vol. 36 (1) , 79-84
RetractedRETRACTED: Metabolic response to omega-3 fatty acid supplementation in patients with diabetic nephropathy: A randomized, double-blind, placebo-controlled trial